We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+7.88%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.51B
AUM Growth
+$99.7M
Cap. Flow
-$170M
Cap. Flow %
-3.09%
Top 10 Hldgs %
18.48%
Holding
1,445
New
336
Increased
635
Reduced
341
Closed
112

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$53.9M
2
PDD icon
Pinduoduo
PDD
+$47.7M
3
LOGC
ContextLogic
LOGC
+$25.5M
4
TDUP icon
ThredUp
TDUP
+$25.1M
5
UPWK icon
Upwork
UPWK
+$24.9M

Top Sells

Rank Stock Value
1
RVLV icon
Revolve Group
RVLV
+$66M
2
NTES icon
NetEase
NTES
+$50.7M
3
TRIP icon
TripAdvisor
TRIP
+$46.2M
4
GRPN icon
Groupon
GRPN
+$44.5M
5
QVCGA
QVC Group Inc Series A
QVCGA
+$43.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 30%
2 Technology 24.74%
3 Communication Services 13.13%
4 Financials 5.61%
5 Industrials 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
1251
DELISTED
Esperion Therapeutics
ESPR
$13K ﹤0.01%
640
+5
+0.8% +$120
EYE icon
1252
National Vision
EYE
$1.81B
$13K ﹤0.01%
+265
New +$13K
KALV
1253
DELISTED
KalVista Pharmaceuticals
KALV
$13K ﹤0.01%
555
+25
+5% +$654
OTLY
1254
Oatly Group
OTLY
$438M
$13K ﹤0.01%
+28
New +$13.9K
PAHC icon
1255
Phibro Animal Health
PAHC
$1.39B
$13K ﹤0.01%
465
+5
+1% +$135
SFM icon
1256
Sprouts Farmers Market
SFM
$8.01B
$13K ﹤0.01%
+552
New +$14.7K
SPPI
1257
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$13K ﹤0.01%
3,675
+340
+10% +$1.18K
CLVS
1258
DELISTED
Clovis Oncology, Inc.
CLVS
$13K ﹤0.01%
2,380
+15
+0.6% +$88
APLT
1259
DELISTED
Applied Therapeutics
APLT
$12K ﹤0.01%
595
+15
+3% +$284
DNTH icon
1260
Dianthus Therapeutics
DNTH
$6.09B
$12K ﹤0.01%
83
+15
+22% +$2.75K
RLMD icon
1261
Relmada Therapeutics
RLMD
$527M
$12K ﹤0.01%
380
+10
+3% +$347
TCRT icon
1262
Alaunos Therapeutics
TCRT
$4.86M
$12K ﹤0.01%
33
+1
+3% +$467
EGRX
1263
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$12K ﹤0.01%
300
+10
+3% +$413
ISEE
1264
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$12K ﹤0.01%
2,055
+20
+1% +$129
PRVB
1265
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$12K ﹤0.01%
1,445
+10
+0.7% +$81
LKFT
1266
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$11K ﹤0.01%
165
+45
+38% +$3.43K
HPQ icon
1267
HP
HPQ
$27.5B
$11K ﹤0.01%
+385
New +$12.3K
XBIT icon
1268
XBiotech
XBIT
$69.2M
$11K ﹤0.01%
685
+20
+3% +$339
ANIP icon
1269
ANI Pharmaceuticals
ANIP
$1.78B
$10K ﹤0.01%
290
+10
+4% +$340
BDTX icon
1270
Black Diamond Therapeutics
BDTX
$112M
$10K ﹤0.01%
825
+5
+0.6% +$99
GERN icon
1271
Geron
GERN
$949M
$10K ﹤0.01%
7,250
+145
+2% +$211
KNSA icon
1272
Kiniksa Pharmaceuticals
KNSA
$5.93B
$10K ﹤0.01%
735
+15
+2% +$228
RNAC icon
1273
Cartesian Therapeutics
RNAC
$268M
$10K ﹤0.01%
86
+4
+5% +$476
SIGA icon
1274
SIGA Technologies
SIGA
$219M
$10K ﹤0.01%
1,730
-60
-3% -$412
TXMD icon
1275
TherapeuticsMD
TXMD
$24M
$10K ﹤0.01%
179
+3
+2% +$182
49 50
51
52 53

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Penserra Capital Management held 1,445 positions worth $5.51B, up 1.8% from $5.41B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Penserra Capital Management withdrew a net $170M in Q2 2021, closing 112 positions and reducing 341 holdings. Its most notable exit was Just Eat Takeaway.com N.V. American Depositary Shares, an estimated $23.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 30% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Penserra Capital Management opened a new position in ContextLogic worth $28.5M.

  • Penserra Capital Management's largest Q2 2021 buy was ContextLogic: 72,047 shares worth $28.5M.
  • Penserra Capital Management added most to Advanced Micro Devices in Q2 2021, an estimated $53.9M increase.
  • Penserra Capital Management's biggest Q2 2021 reduction was Revolve Group, cutting an estimated $66M.
  • Penserra Capital Management fully exited Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, selling an estimated $23.3M.
  • Penserra Capital Management's ten largest holdings make up 18% of its $5.51B portfolio in Q2 2021.
  • Penserra Capital Management opened 336 new positions and closed 112 in Q2 2021.
  • Penserra Capital Management's portfolio value rose 1.8% quarter-over-quarter to $5.51B.

Based on Penserra Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.